Phylogica sinks on licensing setback

Shares in Subiaco-based biotech firm Phylogica have plummeted on the ASX after a potential licensing deal with a subsidiary of pharmaceutical giant Johnson & Johnson effectively collapsed.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer